<DOC>
	<DOCNO>NCT01538316</DOCNO>
	<brief_summary>The aim randomize control double-blind crossover trial evaluate effectiveness two dietary supplement contain polyphenolic phytochemical ( isoflavonoid genistein flavonoid quercetin ) comparison placebo rate increase prostate-specific antigen ( PSA ) . In addition , secondary objective evaluate incidence prostate cancer analyze malondialdehyde protein carbonyle indicator oxidative status .</brief_summary>
	<brief_title>Prostate Cancer Prevention Trial With Quercetin Genistein</brief_title>
	<detailed_description>Prostate cancer ( PC ) frequently occur cancer men . Its clinical incidence mortality rate vary geographically , much low Asia Western country . Notably , latent PCs seem equally distribute , thus support hypothesis , environmental factor may important prostate cancer progression . Moreover , epidemiological evidence strongly support concept incidence clinical prostate cancer depend lifestyle factor , mainly related diet . The isoflavone genistein flavonoid quercetin identify likely preventive candidate . The aim intend clinical trial evaluate hypothesize effectiveness polyphenolic phytochemical highly purify dietary supplement patient high risk clinical PC without systemic treatment . This provide data , serve important pre-requesite target dietary intervention use alternative medicine preventive measure men latent PC .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Genistein</mesh_term>
	<mesh_term>Quercetin</mesh_term>
	<criteria>Patients deviant PSA constellation : 1 . Patients PSA 2,5 4 μg/l free PSA/total PSA &lt; 15 % 2 . Patients PSA &gt; 4 μg/l negative punch biopsy prostate chronic liver disease , impair kidney function inflammatory diseases urogenital tract history malignancy organ system , treat untreated , within past three year whether evidence local recurrence metastasis therapy Doxazosin , Dutaserid and/ Finasterid , Testosteron hormonal active medicament inflammatory bowel disease malabsorption/digestion hypersensitivity/allergy soy phytotherapy intake dietary supplement smoker abnormal clinical laboratory value baseline participation trial investigational new drug inability sign inform consent</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Prostate cancer</keyword>
	<keyword>dietary supplement</keyword>
	<keyword>quercetin</keyword>
	<keyword>genistein</keyword>
	<keyword>prostate-specific antigen</keyword>
	<keyword>oxidative Status</keyword>
</DOC>